•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy
Agenus Announces Peer-Reviewed Publication Linking BOT+BAL's Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-Priming Mechanism
Maison Solutions Eliminates All Outstanding Convertible Notes, Removing Legacy Financing Overhang
Maison Solutions Inc. Receives Nasdaq Notification Regarding Delayed Filing of Annual Report on Form 10-K
ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform"
Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer
Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal
Maison Solutions Inc. Receives 2026 Global Recognition Award in Innovation Category
Maison Solutions Issues Letter to Shareholders on Operational Reset, Recent Transaction Value and the Company's Path Forward
Maison Solutions Regains Compliance with Nasdaq Annual Meeting Requirement
Maison Solutions Signs Definitive Agreement to Establish Majority-Controlled AI Technology Platform
Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth
Maison Solutions Announces Reverse Stock Split
Water Tower Research Publishes Initiation of Coverage Report on Maison Solutions, Inc., "Putting the "AI" in Maison: A Leaner Store Base Meets a Smarter Grocery Platform"
Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial
Why Maison Solutions Shares Are Trading Higher By Over 62%; Here Are 20 Stocks Moving Premarket
Maison Solutions Inc. Enters into Agreement to Divest San Gabriel and Monrovia Store Operations as Part of Strategic Realignment Toward Operational Efficiency and AI-Enabled Growth
Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO GI 2026
Maison Solutions Inc. Announces Strategic Collaboration with SupplyAi and MiniMax to Explore AI-Native Food Supply Chain Solutions
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026